Clinical Trial Update: The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the effects of quetiapine XR in adults with major depressive disorder who exhibit an aberrant N100 amplitude slope.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Quetiapine XR (quetiapine)

Snippet

Sponsor: Inje University | Conditions: Major Depressive Disorder | Phase 4 | Status: UNKNOWN